TrialThe Journal of antimicrobial chemotherapy2015

A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteers.

Samir K Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.